Short-chain fatty acid derivatives stimulate cell proliferation and induce STAT-5 activation

Blood

Volumn 97, Issue 10, 2001, Pages 3259-3267

  Boosalis, Michael S ^a,b,c   Bandyopadhyay, Ram ^a,b,c   Bresnick, Emery H ^a,b,c   Pace, Betty S ^a,b,c   Van Demark, Karyn ^a,b,c   Zhang, Baohua ^a,b,c   Faller, Douglas V ^a,b,c   Perrine, Susan P ^a,b,c  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c UNIVERSITY OF SOUTH ALABAMA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUTYRIC ACID; GAMMA GLOBIN; INTERLEUKIN 3; PROTEIN P21; SHORT CHAIN FATTY ACID; STAT5 PROTEIN;

ACETYLATION; ARTICLE; BURST FORMING UNIT; CELL GROWTH; CELL PROLIFERATION; CELL STIMULATION; ERYTHROID CELL; ERYTHROPOIESIS; GENE CONTROL; GENE LOCUS; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; ONCOGENE C MYB; ONCOGENE C MYC; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REPORTER GENE; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE; YEAST ARTIFICIAL CHROMOSOME;

EID: 0035874544     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V97.10.3259     Document Type: Article

References (88)

1. Burns LJ, Glauber JG, Ginder GD. Butyrate induces selective transcriptional activation of a hypomethylated embryonic globin gene in adult erythroid cells. Blood. 1988;72:1536-1542.
2. Perrine SP, Greene MF, Faller DV. Delay in the fetal globin switch in infants of diabetic mothers. N Engl J Med. 1985;312:334-338.
3. Perrine SP, Rudolph A, Faller DV, et al. Butyrate infusions in the ovine fetal delay the biologic clock for globin gene switching. Proc Natl Acad Sci U S A. 1988;85:8540-8542.
4. Perrine SP, Miller BA, Faller DV, et al. Sodium butyrate stimulates fetal globin gene expression in erythroid progenitors of children with HbSS and beta thalassemia. Blood. 1989;74:454-460,
5. Constantoulakis P, Knitter G, Stamatoyannopoulos G. On the induction of fetal hemoglobin by butyrates: in vivo and in vitro studies with sodium butyrate and comparison with treatments with 5 azaC and araC. Blood. 1989;74:1963-1971.
6. Fibach E, Prasanna P, Rodgers GP, Samid D. Enhanced fetal hemoglobin production by phenylacetate and 4 phenylbutyrate in erythroid progenitors derived from normal donors and patients with sickle cell anemia and beta thalassemia. Blood. 1993;82:2203-2209.
7. Dover GJ, Brusilow S, Charache S. Induction of fetal hemoglobin in subjects with sickle cell anemia by oral sodium phenylbutyrate. Blood. 1994;84:339-343.
8. Liakopoulou E, Blau C, Li Q, et al. Stimulation of fetal hemoglobin by short chain fatty acids. Blood. 1995;86:3227-3235.
9. Perrine SP, Ginder GD, Faller DV, et al. A short-term trial of butyrate to stimulate fetal-globin gene expression in the beta-globin disorders. N Engl J Med. 1993;328:81-86.
10. Bergsagel J, Li Q, Boosalis V, et al. Pulse butyrate therapy in beta thalassemia [abstract]. Blood. 1998;92:529a.
11. Ikuta T, Atweh G, Boosalis V, et al. Cellular and molecular effects of a pulse butyrate regimen and new inducers of globin gene expression and hematopoiesis. Ann N Y Acad Sci. 1998;850:87-99.
12. Atweh GF, Sutton M, Nassif I, et al. Sustained induction of fetal hemoglobin by pulse butyrate therapy in sickle cell disease. Blood. 1999;93:1790-1797.
13. Scher GD, Ginder GD, Little J, Yang S, Dover G, Olivieri NF. Extended therapy with arginine butyrate in patients with beta hemoglobinopathies. N Engl J Med. 1995;332:1606-1610.
14. Bunn HF. Induction of fetal hemoglobin in sickle cell disease. Blood. 1999;93:1787-1789.
15. Wintersberger E, Mudrak I, Wintersberger U. Butyrate inhibits mouse fibroblasts at a control point in the G1 phase. J Cell Biochem. 1983;21:239-247.
16. Toscani A, Soprano DR, Soprano KJ. Sodium butyrate in combination with insulin or dexamethasone can terminally differentiate actively proliferating Swiss 3T3 cells into adipocytes. J Biol Chem. 1990;265:5722-5730.
17. D'Anna JA, Tobey RA, Gurley LR. Concentration-dependent effects of sodium butyrate in Chinese hamster cells: cell-cycle progression, inner-histone acetylation, histone H1 dephosphorylation, and induction of an H1-like protein. Biochemistry. 1980;19:2656-2971.
18. Charollais RH, Buquet C, Mester J. Butyrate blocks the accumulation of CDC2 mRNA in late G1 phase but inhibits both the early and late G1 progression in chemically transformed mouse fibroblasts BP-A31. J Cell Physiol. 1990;145:46-52.
19. Daniell E. Cells inhibited by n-butyrate support adenovirus replication. Virology. 1980;107:514-519,
20. Balk S, Gunther H, Morisi A. Butyrate reversibly arrests the proliferation of normal and Rous sarcoma virus-infected chicken heart mesenchymal cells. Life Sci. 1984;34:803-808.
21. Howard MA, Wardwell S, Albert DM. Effect of butyrate and corticosteroids on retinoblastoma in vitro and in vivo. Invest Ophthalmol Vis Sci. 1991;32:1711-1713.
22. Staiano-Coico L, Khandke L, Krane JF, et al. TGF-alpha and TGF-beta expression during sodium-N-butyrate-inducated differentiation of human keratinocytes: evidence for subpopulation-specific up-regulation of TGF-beta mRNA in suprabasal cells. Exp Cell Res. 1990;191:286-291.
23. Medrano EE, Pardee AB. Prevalent deficiency in tumor cells of cycloheximide-induced cycle arrest. Proc Natl Acad Sci U S A. 1980;77:4123-4126.
24. Shen DW, Real FX, DeLeo AB, Old LJ, Marks PA, Rifkind RA. Protein p53 and inducer-mediated erythroleukemia cell commitment to terminal cell division. Proc Natl Acad Sci U S A. 1983;80:5919-5922.
25. Wintersberger E, Mudrak I. Sodium butyrate inhibits the synthesis of the transformation related protein p53 in 3T6 mouse fibroblasts. FEBS Lett. 1984;166:326-330.
26. Wawra E, Pockl E, Mullner E, Winterberger E. Effect of sodium butyrate on induction of cellular and viral DNA syntheses in polyoma virus-infected mouse kidney cells. J Virol. 1981;38:973-981.
27. Campisi J, Medrano EE, Morreo G, Pardee AB. Restriction point control of cell growth by a labile protein: evidence for increased stability in transformed cells. Proc Natl Acad Sci U S A. 1982;79:436-440.
28. 1 events and regulation of cell proliferation. Science. 1989;246:60-68.
29. Cantley LC, Auger KR, Carpenter C, et al. Oncogenes and signal transduction. Cell. 1991;64:281-302.
30. Sherr CJ. Mammalian G (1)-cyclins. Cell. 1993;73:1059-1065.
31. Vaziri C, Stice L, Faller DV. Butyrate-induced G(1) arrest results from p21-independent disruption of retinoblastoma protein-mediated signals. Cell Growth Differ. 1998;9:465-474.
32. Gong J, Li X, Traganos F, Darzynkiewiez Z. Expression of G(1) and G(2) cyclins measured in individual cells by multiparameter flow cytometry: a new tool in the analysis of the cell cycle. Cell Prolif. 1994;27:357-371.
33. Torkelson S, White B, Faller DV, Phipps K, Pantazis C, Perrine SP. Erythroid progenitor proliferation is stimulated by phenoxyacetic and phenylalkyl acids. Blood Cells Mol Dis. 1996;22:150-158.
34. Boosalis MS, Ikuta T, Pace BS, et al. Abrogation of IL-3 requirements and stimulation of hematopoietic cell proliferation in vitro and in vivo by carboxylic acids. Blood Cells Mol Dis. 1997;23:434-442.
35. White GL, Daftari P, Dover GJ, et al. Stimulation of erythropoiesis and Hb F in vivo with oral hemokines [abstract]. Blood. 1996;88:495a.
36. Greenberger JS, Skakkeeny MA, Humphries RK, Eaves CJ, Eckner RJ. Demonstration of permanent factor-dependent multipotential (erythroid/neutrophil/basophil) hematopoietic progenitor cell lines. Proc Natl Acad Sci U S A. 1983;80:2931-2935.
37. Valtieri M, Tweardy DJ, Caracciolo D, et al. Cytokine-dependent granulocytic differentiation: regulation of proliferative and differentiative responses in a murine progenitor cell line. J Immunol. 1987;138:3829-3835.
38. Askew DS, Ihle JN, Cleveland JL. Activation of apoptosis associated with enforced myc expression in myeloid progenitor cells is dominant to the suppression of apoptosis by interleukin-3 or erythropoietin. Blood. 1993;82:2079-2087.
39. Patel G, Tantravahi R, Oh IH, Reddy EP. Transcriptional activation potential of normal and tumor-associated myb isoforms does not correlate with their ability to block G-CSF-induced terminal differentiation of murine myeloid precursor cells. Oncogene. 1996;13:1197-1208.
40. Ihle JN. STATs: signal transducers and activators of transcription. Cell. 1996;84:331-334.
41. Chin H, Nakamaru N, Kamiyama R, Miyasaka N, Ihle JN, Miura O. Physical and functional interactions between STAT-5 and the tyrosine-phosphorylated receptors for erythropoietin and interleukin-3. Blood. 1996;88:4415-4425.
42. Forsberg EC, Johnson K, Zaboikina TN, Mosser EA, Bresnick EH. Requirement of an EIA-sensitive coactivator for long-range transactivation by the beta globin locus control region. J Biol Chem. 1999;274:26850-26859.
43. Versaw WK, Blank V, Andrews NM, Bresnick EH. Mitogen-activated protein kinases enhance long-range activation by the beta-globin locus control region. Proc Natl Acad Sci U S A. 1998;95:8756-8760.
44. Skarpidi E, Vassilopoulos G, Li Q, Stamtoyannopoulos G. Novel in vitro assay for the detection of pharmacologic inducers of fetal hemoglobin. Blood. 2000;96:321-326.
45. Pace B, Li Q, Stamatoyannopoulos G. Alpha-amino butyric acid cannot reactivate the silenced gamma gene of the beta locus YAC transgenic mouse. Blood. 1994;84:4344-4353.
46. El-Deiry WS, Tokino T, Velculescu VE, et al. WAF1, a potential mediator of p53 tumor suppression. Cell. 1993;75:817-825.
47. Yoshida M, Kijima M, Akita M, Beppu T. Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A. J Biol Chem. 1990;265:17174-17179.
48. Zweidler A. Resolution of histones by polyacrylamide gel electrophoresis in the presence of nonionic detergents. Methods Cell Biol. 1990;17:223-234.
49. Ikuta T, Kan YW, Swerdlow PS, Faller DV, Perrine SP. Alterations in protein-DNA interactions in response to butyrate therapy. Blood. 1998;92:2924-2933.
50. Mui ALF, Wakao H, Kinoshita T, Kitamura T, Miyajima A. Suppression of interleukin-3-induced gene expression by a C-terminal truncated STAT-5: role of STAT-5 in proliferation. EMBO J. 1996;15:2425-2433.
51. Teglund S, McKay C, Schuetz E, et al. STAT-5a and STAT-5b proteins have essential and nonessential, or redundant, roles in cytokine responses. Cell. 1998;93:841-850.
52. Okajima Y, Matsumura I, Nishiura T, et al. Insulin-like growth factor-I augments erythropoietin-induced proliferation through enhanced tyrosine phosphorylation of STAT5. J Biol Chem. 1998;273:22877-22883.
53. Yamashita T, Wakao H, Miyajima A, Asano S. Differentiation inducers modulate cytokine signaling pathways in a murine erythroleukemia cell line. Cancer Res. 1998;58:556-561.
54. Nosaka T, Kawashima T, Misawa K, Ikuta K, Mui ALF, Kitamura T. STAT-5 as a molecular regulator of proliferation, differentiation and apoptosis in hematopoietic cells. EMBO J. 1999;18:4754-4765.
55. Damen JE, Wakao H, Miyajima A, et al. Tyrosine 343 in the erythropoietin receptor positively regulates erythropoietin-induced cell proliferation and STAT-5 activation. EMBO J. 1995;14:5557-5568.
56. Onishi M, Nosaka T, Misawa K, et al. Indentification and characterization of a constitutively active STAT-5 mutant that promotes cell proliferation. Mol Cell Biol. 1998;3871-3879.
57. Sillaber C, Gesbert F, Frank DA, Griffin JD. STAT5 activation contributes to growth and viability in Bcr/Abl-transformed cells. Blood. 2000;95:2118-2125.
58. Callus BA, Mathey-Prevot B. Interleukin-3-induced activation of the JAK/STAT pathway is prolonged by proteasome inhibitors. Blood. 1998;91:3182-3192.
59. Soldatenkov VA, Prasad S, Voloshin Y, Dritschilo A. Sodium butyrate induces apoptosis and accumulation of ubiquitinated proteins in human breast carcinoma cells. Cell Death Differ. 1998;5:307-312.
60. Haspel RL, Salditt-Georgieff M, Darnell JE Jr. The rapid inactivation of nuclear tyrosine phosphorylated Stat1 depends upon a protein tyrosine phosphatase. EMBO J. 1996;15:6262-6270.
61. Lee C, Piazza F, Brutsaert S, et al. Characterization of the Stat5 protease. J Biol Chem. 1999;274:26767-26775.
62. Cuisset L, Tichonicky L, Jaffray P, Delpech M. The effects of sodium butyrate on transcription are mediated through activation of a protein phosphatase. J Biol Chem. 1997;272:24148-24153.
63. Wolff L. Myb-induced transformation. Crit Rev Oncog. 1996;7:245-260.
64. Oh IH, Reddy EP. Murine A-myb gene encodes a transcription factor, which cooperates with Ets-2 and exhibits distinctive biochemical and biological activities from c-myb. J Biol Chem. 1997;272:21432-21443.
65. Filippovich I, Sorokina N, Khanna KK, Lavin MF. Butyrate induced apoptosis in lymphoid cells preceded by transient over-expression of hsp70 mRNA. Biochem Biophys Res Commun. 1994;198:257-265.
66. Manning AM, Hague A, Paraskeva C. Role of transforming growth factor-beta and the dietary factor sodium butyrate in the control of proliferation and apoptosis in colorectal carcinogenesis. In: Marks PA, Turler H, Weil R, eds. Precancerous Lesions: A Multidisciplinary Approach. Rome, Italy: Ares-Serono Symposia Publications; 1993:1-150.
67. Calabresse C, Venturini L, Ronco G, et al. Selective induction of apoptosis in myeloid leukemic cell lines by monoacetone glucose-3 butyrate. Biochem Biophys Res Commun. 1994;201:266-283.
68. Hague A, Elder DJE, Hicks DJ, Paraskeva C. Apoptosis in colorectal tumors cells: induction by the short chain fatty acids butyrate, propionate, and acetate and by the bile salt deoxycholate. Int J Cancer. 1995;60:400-406.
69. Hague A, Butt AJ, Paraskeva C. The role of butyrate in human colonic epithelial cells: an energy source or inducer of differentiation and apoptosis? Proc Nutr Soc. 1996;55:937-943.
70. Zimra Y, Wasserman L, Maron L, Shaklai M, Nudelman A, Rephaeli A. Butyric acid and pivaloyloxymethyl butyrate, AN-9, a novel butyric acid derivative, induce apoptosis in HL-60 cells. J Cancer Res Clin Oncol. 1997;123:152-160.
71. McBain JA, Eastman A, Nobel CS, Mueller GC. Apoptotic death in adenocarcinoma cell lines induced by butyrate and other histone deacetylase inhibitors. Biochem Pharmacol. 1997;53:1357-1368.
72. Boisteau O, Gautier F, Cordel SK, et al. Apoptosis induced by sodium butyrate treatment increases immunogenicity of a rat colon tumor cell line. Apoptosis. 1997;2:403-412.
73. Chung DH, Zhang FF, Chen F, McLaughlin WP, Ljungman M. Butyrate attenuates BCLXL expression in human fibroblasts and acts in synergy with ionizing radiation to induce apoptosis. Radiat Res. 1998;149:187-194.
74. Bonnotte B, Favre N, Reveneau S, et al. Cancer cell sensitization to Fas-mediated apoptosis by sodium butyrate. Cell Death Diff. 1998;5:480-487.
75. Santini V, Scappini B, Gozzini A, et al. Butyratestable monosaccharide derivatives induce maturation and apoptosis in human acute myeloid leukaemia cells. Br J Haematol. 1998;101:529-538.
76. Conway RM, Madigan MC, Billson FA, Penfold PL. Vincristine- and cisplatin-induced apoptosis in human retinoblastoma: potentiation by sodium butyrate. Eur J Cancer. 1998;34:1741-1748.
77. Liu WH, Yung BYM. Mortalization of human promyelocytic leukemia HL-60 cells to be more susceptible to sodium butyrate induced apoptosis and inhibition of telomerase activity by down-regulation of nucleophosmin/B23. Oncogene. 1998;17:3055-3064.
78. Weinberg RA. The retinoblastoma protein and cell cycle control. Cell. 1995;81:323-330.
79. Herwig S, Srauss M. The Rb protein: a master regulator of cell cycle, differentiation and apoptosis. Eur J Biochem. 1997;246:581-601.
80. Ko LJ, Prives C. p53: puzzle and paradigm. Genes Dev. 1996;10:1054-1072.
81. Scherr CJ, Roberts JM. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 1995;9:1149-1163.
82. Nakano K, Mizuno T, Sowa Y, et al. Butyrate activates the WAF1/Cip1 gene promoter through Sp1 sites in a p53-negative human colon cancer cell line. J Biol Chem. 1997;272:22199-22206.
83. Cousens LS, Gallwitz D, Alberts BM. Different accessibilities in chromatin to histone acetylase. J Biol Chem. 1979;254:1716-1723.
84. Csordas A. On the biological role of histone acetylation. Biochem J. 1990;265:23-38.
85. Davie JR, Hendzel, MJ. Multiple functions of dynamic histone acetylation. J Cell Biochem. 1994;55:98-105.
86. Schroter H, Gomez-Lira MM, Plank KH, Bode J. The extent of histone acetylation induced by butyrate and the turnover of acetyl groups depend on the nature of the cell line. Eur J Biochem. 1981;120:21-28.
87. Van Lint C, Emiliani S, Ott M, Verdin E. The expression of a small fraction of cellular genes is changed in response to histone hyperacetylation. Gene Expression. 1996;5:245-253.
88. Sutton M, Nassif I, Stamatoyannopoulos G, Perrine SP, Atweh GF. Absence of cross-resistance to the Hb F stimulating activities of butyrate and hydroxyurea [abstract]. Blood. 1998;92:694a.